# US 2026/0021223 A1 · Hydrogel fillers for conformable fillable medical balloons

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0021223 A1
- Document ID: US20260021223A1
- Status: Published application
- Kind: A1
- Application number: 19/270,195
- Filed: 2025-07-15
- Published: 2026-01-22
- Earliest claimed: 2024-07-18
- Assignees: Boston Scientific Scimed, Inc.
- Applicants: Boston Scientific Scimed, Inc.
- Inventors: Nicolas Ball-Jones; Rick William Dorn; Cristian Parisi; Joseph Thomas Delaney, Jr.
- Web page: https://patentgrep.com/patent/US20260021223A1

## CPC

- A61L 27/52: Hydrogels or hydrocolloids
- A61L 31/145: {Hydrogels or hydrocolloids}
- A61B 17/12109: {in a blood vessel}
- A61B 17/12122: {within the heart (for closing a cardiac septal defect A61B17/0057)}
- A61B 17/12136: {Balloons}
- A61B 17/24: for use in the oral cavity, larynx, bronchial passages or nose (for medical inspection of cavities or tubes in the body A61B1/00); Tongue scrapers
- A61F 2/02: Prostheses implantable into the body
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00557: {inflatable (A61B2017/22051 takes precedence)}
- A61B 2017/00792: {Plastic surgery}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/00898: {expandable upon contact with fluid}
- A61B 2017/00951: {adhesive}
- A61B 2090/0481: {against EM radiation, e.g. microwave}
- A61F 2/30: Joints
- A61F 2002/30581: {having a pocket filled with fluid, e.g. liquid}
- A61F 2250/0003: having an inflatable pocket filled with fluid, e.g. liquid or gas
- A61L 2400/06: Flowable or injectable implant compositions
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

In various aspects, the present disclosure pertains to balloon implantation kits comprising: (a) a balloon configured to be implanted in a mammalian body and (b) a reservoir containing a filler material that is configured to be injected into the balloon, the filler material selected from a hydrogel filler material comprising crosslinked hydrophilic polymer chains or hydrogel precursors that form a hydrogel filler material in the balloon when combined.

## Claims

### Claim 1

A balloon implantation kit comprising: (a) a balloon configured to be implanted in a mammalian body and (b) a reservoir containing a filler material that is configured to be injected into the balloon, the filler material selected from a hydrogel filler material comprising crosslinked hydrophilic polymer chains or hydrogel precursors that form a hydrogel filler material in the balloon when combined.

### Claim 2 (depends on 1)

The balloon implantation kit of claim 1, wherein the crosslinked hydrophilic polymer chains are crosslinked by crosslinks that comprise hydrolysable linkers.

### Claim 3 (depends on 2)

The balloon implantation kit of claim 2, wherein the hydrolysable linkers are selected from a carbonate linker, an acid anhydride linker, an imide linker, a ketal linker, a carbamate linker, an organophosphate ester linker, a silane linker, an amide linker, a hydrozonium linker, an acylhydrozone linker, an oxime linker and an amidohydrozone linker.

### Claim 4 (depends on 2)

The balloon implantation kit of claim 2, wherein the crosslinks further comprise an activating group positioned adjacent to the hydrolysable linkers, which increases a rate of hydrolysis of the hydrolysable linkers.

### Claim 5 (depends on 4)

The balloon implantation kit of claim 4, wherein the activating group is selected from a hydrogen bond donor, a hydrogen bond acceptor, a lone pair donor, a lone pair acceptor, a silicon containing group, a boron containing group, a phosphonate group and a sulfonate group.

### Claim 6 (depends on 4)

The balloon implantation kit of claim 4, wherein the activating group is selected from a urea linker, a urea pendant group, a thiourea linker, a thiourea pendant group, an amine linker, an amine pendant group, an alcohol pendant group, a silicon-containing linker, a silicon-containing pendant group, a boron-containing linker, a boron-containing pendant group, a phosphonate linker, a phosphonate pendant group, and a sulfonate pendant group.

### Claim 7 (depends on 1)

The balloon implantation kit of claim 1, wherein the crosslinked hydrophilic polymer chains are crosslinked by crosslinks that comprise immolative linkers or by crosslinks that comprise reversible covalent linkers that incorporate reactive dimeric linkers.

### Claim 8 (depends on 7)

The balloon implantation kit of claim 7, wherein the kit further comprises a cleavage composition that contains a singly reactive molecule that acts to break the crosslinks at a position of the immolative linkers within the crosslinks or wherein the cleavage composition contains a singly reactive molecule that acts to break the crosslinks at a position of the dimeric linkers within the crosslinks.

### Claim 9 (depends on 8)

The balloon implantation kit of claim 8, wherein the kit comprises a syringe barrel that contains the cleavage composition.

### Claim 10 (depends on 8)

The balloon implantation kit of claim 8, wherein the hydrophilic polymer hydrogel comprises the hydrophilic polymer chains that are crosslinked by crosslinks that comprise immolative linkers and wherein the hydrogel cleavage composition contains the singly reactive molecule that acts to break the crosslinks at the position of the immolative linkers within the crosslinks.

### Claim 11 (depends on 8)

The balloon implantation kit of claim 8, wherein the hydrophilic polymer hydrogel comprises the hydrophilic polymer chains that are crosslinked by crosslinks that contain reversible covalent linkers that incorporate a reactive dimeric linker and wherein the hydrogel cleavage composition contains the singly reactive molecule that acts to break the crosslinks at the position of the dimeric linkers within the crosslinks.

### Claim 12 (depends on 1)

The balloon implantation kit of claim 1, wherein the hydrophilic polymer chains are selected from polyalkylene oxide chains, polyester chains, polyoxazoline chains, polydioxanone chains, polypeptide chains, polyacrylate chains, and polyacrylamide chains, or combinations thereof.

### Claim 13 (depends on 1)

The balloon implantation kit of claim 1, wherein the filler material is a shear-thinning hydrogel material.

### Claim 14 (depends on 13)

The balloon implantation kit of claim 13, wherein the shear-thinning hydrogel material comprises fibrous protein, silicate particles and water.

### Claim 15 (depends on 1)

The balloon implantation kit of claim 1, wherein the filler material is a lower critical solution temperature material that is in the form of a hydrogel at body temperature.

### Claim 16 (depends on 1)

The balloon implantation kit of claim 1, wherein the filler material comprises hydrogel precursors that form a hydrogel in the balloon when combined.

### Claim 17 (depends on 1)

The balloon implantation kit of claim 1, wherein balloon is biodegradable.

### Claim 18

A balloon implantation kit comprising: (a) a balloon configured to be implanted in a mammalian body; (b) a reservoir containing a filler material that is configured to be injected into the balloon, the filler material selected from a hydrogel filler material comprising crosslinked hydrophilic polymer chains or hydrogel precursors that form a hydrogel filler material in the balloon when combined; and (c) an elongate filling tube that is configured to be removably coupled to the conformable, fillable balloon, the elongate filling tube having a lumen that is configured for fluid communication with an interior of the conformable, fillable balloon.

### Claim 19 (depends on 18)

The balloon implantation kit of claim 18, wherein the kit further comprises a delivery sheath.

### Claim 20

A method comprising contacting an implant, which implant comprises a conformable, fillable balloon and a hydrogel filler material disposed within the conformable, fillable balloon that comprises a hydrophilic polymer hydrogel comprising crosslinked hydrophilic polymer chains that are crosslinked by crosslinks that comprise immolative linkers or by crosslinks that contain reversible covalent linkages that incorporate reactive dimeric linkers, with a cleavage composition that contains a singly reactive molecule that acts to break the crosslinks at a position of the immolative linkers within the crosslinks or at a position of the dimeric linkers within the crosslinks, thereby accelerating breakdown of the conformable, fillable balloon.
